Re: Not good for the potential of apabetalone as a Covid-19 therapy
in response to
by
posted on
Nov 29, 2021 05:58PM
BKC,
I appreciate your previous post. However I find it confusing. I thought that preventing replication of the virus was the way APB keeps Covid from becoming overly harmful/deadly. Meaning, to me, that it should be administered early on, to prevent the viral load from becoming large. Your post seems to say the opposite, that it should be used after Covid has produced harmful symptoms.
Can you help me on this?